<- Go Home

AmpliPhi Biosciences Corporation

As of May 9, 2019, was acquired by C3J Therapeutics, Inc., in a reverse merger transaction.

Market Cap

$11.1M

Volume

25.7K

Cash and Equivalents

$5.5M

EBITDA

-$10.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$4.9M

Profit Margin

N/A

52 Week High

$19.18

52 Week Low

$2.15

Dividend

N/A

Price / Book Value

2.19

Price / Earnings

-0.63

Price / Tangible Book Value

5.46

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$11.1M

Return on Equity

154.98%

Return on Assets

-58.01

Cash and Short Term Investments

$5.5M

Debt

N/A

Equity

$5.0M

Revenue

N/A

Unlevered FCF

-$4.2M

Sector

Biotechnology

Category

N/A

Company Stock Pitches